Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain
Launched by MOUNT SINAI HOSPITAL, CANADA · Sep 23, 2014
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18-65
- • Have nociceptive scrotal pain,
- • Have no identifiable, reversible causes for the scrotal pain
- • Have failed standard medical therapy
- • Have responded temporarily to cord blocks
- Exclusion Criteria:
- • Are interested in trying to conceive with their partners in the next 6 months,
- • Have any local infection near the site of the injections,
- • Have had an allergic reaction to Botox in the past,
- • Are unable to provide informed consent
- • Have a history of motor neuron disease or neurogenic bladder
- • Who have hemostatic disorder or who are taking aspirin, Coumadin (warfarin), Xarelto (rivaroxaban) or other blood thinners
About Mount Sinai Hospital, Canada
Mount Sinai Hospital, located in Canada, is a leading academic health institution renowned for its commitment to innovative research and high-quality patient care. As a sponsor of clinical trials, Mount Sinai Hospital leverages its extensive expertise in various medical disciplines to advance clinical knowledge and develop new therapies. The hospital collaborates with a diverse network of healthcare professionals, researchers, and institutions to conduct rigorous trials that aim to improve health outcomes and enhance the quality of life for patients. With a focus on ethical standards and patient safety, Mount Sinai Hospital is dedicated to translating scientific discoveries into effective clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Keith Jarvi, MD
Principal Investigator
Mount Sinai Hospital, Canada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials